BEACH Trial: Bovine Early Access, Compatibility and Hemostasis Trial

PHASE3TerminatedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 3, 2019

Primary Completion Date

June 16, 2020

Study Completion Date

June 16, 2020

Conditions
Renal Insufficiency,Chronic
Interventions
DEVICE

Artegraft® Collagen Vascular Graft™ (Artegraft)

The Artegraft is intended for use distal to the aorta as a segmental arterial replacement, as an arterial bypass, as an arteriovenous shunt where more conventional methods have proven inadequate, or as an arterial patch graft.

Trial Locations (5)

12209

Capital District Renal Physicians, Albany

29118

Dialysis Access Institute, Orangeburg

29303

Spartanburg Regional Medical Center, Spartanburg

75218

City Hospital at White Rock, Dallas

92093

University of California, San Diego

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Artegraft, Inc.

INDUSTRY

NCT04146012 - BEACH Trial: Bovine Early Access, Compatibility and Hemostasis Trial | Biotech Hunter | Biotech Hunter